Translate
Gossamer Bio, Inc.
About
0.21USD+0.01 +4.58%
Closed • Updated at 10:47 GMT+00:00Market Cap$49.31M
Volume12.80M
Beta0.59
RSI29.15
Gross Margin98.39%
Gossamer Bio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
May 18 2026
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
May 15 2026
Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026
Mar 17 2026
Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Feb 23 2026
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension
Recent Videos
Gossamer Bio Inc (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure
May 12, 2026
GOSS Stock Analysis Today Gossamer Bio Stock Prediction & Price Target GOSS Stock Forecast & News
May 04, 2026
![Gossamer Bio, Inc. [GOSS] Case Explained](https://i.ytimg.com/vi/RihZxjKc2dU/hqdefault.jpg)
Gossamer Bio, Inc. [GOSS] Case Explained
Apr 28, 2026
GOSS Stock Analysis Today Gossamer Bio Stock Prediction & Price Target GOSS Stock Forecast & News
Apr 28, 2026